期刊文献+

~99TC^m-HYNIC-Annexin V的制备及其在健康小鼠体内的分布 被引量:9

Preparation of 99~Tc^m-HYNIC-Annexin V and its biodistribution study in normal mice
下载PDF
导出
摘要 目的制备人膜联蛋白 V(Annexin V),应用联肼尼克酰胺(HYNIC)偶联后进行^(99)Tc^m 标记,评价^(99)Tc^m-HYNIC-Annexin V 在健康小鼠体内的分布。方法采用基因工程方法构建 Annexin V 的原核载体并诱导其表达,与自行合成的双功能螯合剂 HYNIC 偶联,并进行^(99)Tc^m 标记。测定^(99)Tc^m-HYNIC-Annexin V 的标记率、放化纯,并研究其在健康小鼠体内的生物分布特性。结果 Annexin V在大肠杆菌中获得稳定表达,经十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)及 Western Blot-ting 检测,得到纯度较高的蛋白质。Annexin V 经 HYNIC 偶联后,其^(99)Tc^m 标记率可达90%左右,放化纯>90%。小鼠体内分布结果表明,^(99)Tc^m-HYNIC-Annexin V 血液清除迅速,主要从肾脏和肝脏排泄。结论 Annexin V 可在原核生物中稳定表达。其与 HYNIC 偶联后,^(99)Tc^m 标记率和放化纯较高,方法简单,条件温和。 Objective To prepare ^99Tc^m labeled Annexin V ,conjugated with hydrazinonictinamide (HYNIC) and to evaluate its biodistribution in normal mice. Methods Plasmid of human Annexin V was constructed by gene engineering method and was expressed in E. coll.. HYNIC was prepared and used as bifunctional chelate agent for ^99Tc^m labeling. The radiochemical purity, radiolabeling yield and biodistribution of ^99Tc^m-HYNIC-Annexin V were studied. Results The coding sequence of human Annexin V gene was successfully cloned into the expression vector, and highly expressed in E. coli, . Highly purified protein could be obtained and confirmed by Western Blotting and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), The radiochemical purity was over 90% , and the radiolabeling yield reached 90%. The biodistribution in normal mice showed it quickly removed from blood and excreted mainly through kidney and liver. Conclusions Annexin V could be stably expressed in E, coli, and high radiochemical purity and radiolabelling yield gained when conjugated with HYNIC and then labeled with ^99Tc^m. It is an easy and smooth labeling method.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2005年第6期344-346,共3页 Chinese Journal of Nuclear Medicine
基金 高等学校博士点专项科研基金项目(20030487013)
关键词 膜联蛋白V 同位素标记 药代动力学 小鼠 Annexin V Isotope labeling Pharmacokinetics Mice
  • 相关文献

参考文献11

  • 1Abrams MJ,Juweid M,Tenkate CI,et al.^99Tc^m-human polyclonal IgG radiolabeled via the hydrazine nicotinamide derivative for imaging focal sites of infection in rats.J Nucl Med,1990,31:2022-2028.
  • 2Strausberg RL,Feingold EA,Grouse LH,et al.Generation and initial analysis of more than 15000 full-length human and mouse cDNAsequence.Proc Natl Acad Sci USA,2002,99:16899-16903.
  • 3Blankenberg FG,Tait J,Ohtsuki K,et al.Apoptosis:the importance of nuclear medicine.Nucl Med C ommun,2000,21:241-250.
  • 4Takei T,Kuge Y,Zhao S,et al.Time course of apoptotic tumor response after a single dose of chemotherapy:comparison with 99TcmAnnexin V uptake and histologic findings in an experimental model.JNucl Med,2004,45:2083-2087.
  • 5Kartachova M,Haas RL,Olmos RA,et al.In vivo imaging of apoptosis by ^99Tc^m-Annexin V scintigraphy:visual analysis in relation to treatment response.Radiother Oncol,2004,72:333-339.
  • 6Kemerink GJ,Liem IH,Hofstra L,et al.Patient dosimetry of intravenously administered ^99Tc^m-Annexin V.J Nucl Med,2001,42:382-387.
  • 7Kemerink GJ,Boersma HH,Thimister PWL,et al.Biodistribution and dosimetry of ^99Tc^m-BTAP-Annexin V in humans.Eur J Nucl Med Mol Imaging,2001,28:1373-1378.
  • 8Purohit A,Liu S,Casebier D,et al.Phosphine-containing HYNICderivatives as potential bifunctional chelators for ^99Tc^m labeling of small biomolecules.Bioconjug Chem,2003,14:720-727.
  • 9Verbeke K,Kieffer D,Vanderheyden JL,et al.Optimization of the preparation of ^99Tc^m labeled HYNIC-derivatized Annexin V for human use.Nucl Med Biol,2003,30:771-778.
  • 10Blankenberg FG,Katsikis PD,Tait JF,et al.Imaging of apoptosis(programmed cell death)with ^99Tc^m-Annexin V.J Nucl Med,1999,40:184-191.

同被引文献102

引证文献9

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部